红斑-话题@MedSci

#红斑#

351篇内容 | 5556人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1436342, encodeId=c8ac14363428d, content=<a href='/topic/show?id=22f8e71238d' target=_blank style='color:#2F92EE;'>#红斑#</a>, objectTitle=Ann Hematol：免疫性血小板减少症发展为系统性红斑狼疮的潜在危险因素：中国儿童病例对照研究, objectType=article, longId=727295, objectId=7a10e2729516, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a10e2729516, replyNumber=0, likeNumber=112, createdTime=2022-05-20, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a10e2729516, moduleTitle=Ann Hematol：免疫性血小板减少症发展为系统性红斑狼疮的潜在危险因素：中国儿童病例对照研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a10e2729516)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1436340, encodeId=d83e1436340c6, content=<a href='/topic/show?id=22f8e71238d' target=_blank style='color:#2F92EE;'>#红斑#</a>, objectTitle=A&R：系统性红斑狼疮的共享和亚洲特异性基因座的鉴定以及III型干扰素信号传导和溶酶体功能在该疾病中作用的证据：一项多祖先全基因组关联研究, objectType=article, longId=727241, objectId=7c72e2724187, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7c72e2724187, replyNumber=0, likeNumber=139, createdTime=2022-05-19, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7c72e2724187, moduleTitle=A&R：系统性红斑狼疮的共享和亚洲特异性基因座的鉴定以及III型干扰素信号传导和溶酶体功能在该疾病中作用的证据：一项多祖先全基因组关联研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7c72e2724187)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1436339, encodeId=e92e14363391a, content=<a href='/topic/show?id=22f8e71238d' target=_blank style='color:#2F92EE;'>#红斑#</a>, objectTitle=病程越长越容易复发？牢记4点，让红斑狼疮不敢复发！, objectType=article, longId=727013, objectId=076be270131f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=076be270131f, replyNumber=0, likeNumber=106, createdTime=2022-05-17, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=076be270131f, moduleTitle=病程越长越容易复发？牢记4点，让红斑狼疮不敢复发！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=076be270131f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1436344, encodeId=9717143634473, content=<a href='/topic/show?id=22f8e71238d' target=_blank style='color:#2F92EE;'>#红斑#</a>, objectTitle=Arch Dermatol Res：非手术短波射频治疗轻至中度红斑型酒糟鼻, objectType=article, longId=726588, objectId=7ff4e26588c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7ff4e26588c6, replyNumber=0, likeNumber=0, createdTime=2022-05-12, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7ff4e26588c6, moduleTitle=Arch Dermatol Res：非手术短波射频治疗轻至中度红斑型酒糟鼻, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7ff4e26588c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1436338, encodeId=a0d4143633819, content=<a href='/topic/show?id=22f8e71238d' target=_blank style='color:#2F92EE;'>#红斑#</a>, objectTitle=C3、C4补体在系统性红斑狼疮的诊疗中为何如此重要？, objectType=article, longId=724924, objectId=d964e2492461, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d964e2492461, replyNumber=0, likeNumber=99, createdTime=2022-04-26, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d964e2492461, moduleTitle=C3、C4补体在系统性红斑狼疮的诊疗中为何如此重要？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d964e2492461)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1436337, encodeId=9639143633e17, content=<a href='/topic/show?id=22f8e71238d' target=_blank style='color:#2F92EE;'>#红斑#</a>, objectTitle=Rheumatology：暴露-反应分析在系统性红斑狼疮患者阿尼福卢单抗更佳剂量方案选择中的应用, objectType=article, longId=301331, objectId=80cb301331b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=80cb301331b1, replyNumber=0, likeNumber=97, createdTime=2022-03-23, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=80cb301331b1, moduleTitle=Rheumatology：暴露-反应分析在系统性红斑狼疮患者阿尼福卢单抗更佳剂量方案选择中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=80cb301331b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1436336, encodeId=9fae143633638, content=<a href='/topic/show?id=22f8e71238d' target=_blank style='color:#2F92EE;'>#红斑#</a>, objectTitle=Arthritis Rheumatol：Bruton‘s酪氨酸激酶抑制剂Fenebrutinib治疗系统性红斑狼疮的疗效、安全性和药效学效应研究, objectType=article, longId=301207, objectId=11cf30120ed4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=11cf30120ed4, replyNumber=0, likeNumber=42, createdTime=2022-03-21, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=11cf30120ed4, moduleTitle=Arthritis Rheumatol：Bruton‘s酪氨酸激酶抑制剂Fenebrutinib治疗系统性红斑狼疮的疗效、安全性和药效学效应研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=11cf30120ed4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1436335, encodeId=0ee21436335ed, content=<a href='/topic/show?id=22f8e71238d' target=_blank style='color:#2F92EE;'>#红斑#</a>, objectTitle=J Autoimmun：皮肤CD4+Trm细胞区分急性皮肤红斑狼疮和局限性盘状红斑狼疮/亚急性皮肤红斑狼疮及其他皮肤病, objectType=article, longId=301190, objectId=2e5b30119004, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e5b30119004, replyNumber=0, likeNumber=91, createdTime=2022-03-21, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e5b30119004, moduleTitle=J Autoimmun：皮肤CD4+Trm细胞区分急性皮肤红斑狼疮和局限性盘状红斑狼疮/亚急性皮肤红斑狼疮及其他皮肤病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e5b30119004)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1436334, encodeId=4bed1436334e4, content=<a href='/topic/show?id=22f8e71238d' target=_blank style='color:#2F92EE;'>#红斑#</a>, objectTitle=JEADV:1例斑块型银屑病患者在接种新冠疫苗后出现泛发性脓疱性银屑病红斑，并用risankizumab成功治疗, objectType=article, longId=301106, objectId=c6303011065d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6303011065d, replyNumber=0, likeNumber=103, createdTime=2022-03-20, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6303011065d, moduleTitle=JEADV:1例斑块型银屑病患者在接种新冠疫苗后出现泛发性脓疱性银屑病红斑，并用risankizumab成功治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c6303011065d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1436333, encodeId=5790143633310, content=<a href='/topic/show?id=22f8e71238d' target=_blank style='color:#2F92EE;'>#红斑#</a>, objectTitle=Front Immunol：单细胞分辨下系统性红斑狼疮患者外周血单核细胞染色质可及性的研究, objectType=article, longId=301050, objectId=55b33010502d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55b33010502d, replyNumber=0, likeNumber=0, createdTime=2022-03-19, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55b33010502d, moduleTitle=Front Immunol：单细胞分辨下系统性红斑狼疮患者外周血单核细胞染色质可及性的研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55b33010502d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1436332, encodeId=639f1436332d1, content=<a href='/topic/show?id=22f8e71238d' target=_blank style='color:#2F92EE;'>#红斑#</a>, objectTitle=NEJM：iberdomide治疗系统性红斑狼疮II期结果喜人, objectType=article, longId=301029, objectId=eb7230102925, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb7230102925, replyNumber=0, likeNumber=94, createdTime=2022-03-19, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb7230102925, moduleTitle=NEJM：iberdomide治疗系统性红斑狼疮II期结果喜人, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb7230102925)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1436331, encodeId=22e21436331fd, content=<a href='/topic/show?id=22f8e71238d' target=_blank style='color:#2F92EE;'>#红斑#</a>, objectTitle=Mayo Clin Proc：系统性红斑狼疮和抗磷脂抗体综合征患者发生生物瓣膜血栓的极端病例, objectType=article, longId=300410, objectId=2b63300410f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b63300410f8, replyNumber=0, likeNumber=74, createdTime=2022-03-11, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b63300410f8, moduleTitle=Mayo Clin Proc：系统性红斑狼疮和抗磷脂抗体综合征患者发生生物瓣膜血栓的极端病例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b63300410f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1436329, encodeId=60231436329cb, content=<a href='/topic/show?id=22f8e71238d' target=_blank style='color:#2F92EE;'>#红斑#</a>, objectTitle=ARD：EULAR对风湿性和肌肉骨骼疾病（包括系统性红斑狼疮和抗磷脂综合征）心血管风险管理的建议, objectType=article, longId=299510, objectId=24f02995100e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=24f02995100e, replyNumber=0, likeNumber=91, createdTime=2022-02-25, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=24f02995100e, moduleTitle=ARD：EULAR对风湿性和肌肉骨骼疾病（包括系统性红斑狼疮和抗磷脂综合征）心血管风险管理的建议, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=24f02995100e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1436330, encodeId=5e81143633090, content=<a href='/topic/show?id=22f8e71238d' target=_blank style='color:#2F92EE;'>#红斑#</a>, objectTitle=ARD：系统性红斑狼疮的抗RNP抗体与干扰素基因特征相关，与降低的补体水平无关, objectType=article, longId=299507, objectId=457029950e63, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=457029950e63, replyNumber=0, likeNumber=81, createdTime=2022-02-25, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=457029950e63, moduleTitle=ARD：系统性红斑狼疮的抗RNP抗体与干扰素基因特征相关，与降低的补体水平无关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=457029950e63)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1436328, encodeId=5a5b143632875, content=<a href='/topic/show?id=22f8e71238d' target=_blank style='color:#2F92EE;'>#红斑#</a>, objectTitle=TAMD：FRAX工具评估系统性红斑狼疮患者骨折风险, objectType=article, longId=299198, objectId=b6352991986b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b6352991986b, replyNumber=0, likeNumber=92, createdTime=2022-02-21, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b6352991986b, moduleTitle=TAMD：FRAX工具评估系统性红斑狼疮患者骨折风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b6352991986b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1436327, encodeId=cbfc143632ea1, content=<a href='/topic/show?id=22f8e71238d' target=_blank style='color:#2F92EE;'>#红斑#</a>, objectTitle=阿斯利康旗下的Saphnelo获得欧盟批准用于系统性红斑狼疮, objectType=article, longId=299002, objectId=62eb29900255, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=62eb29900255, replyNumber=0, likeNumber=82, createdTime=2022-02-19, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=62eb29900255, moduleTitle=阿斯利康旗下的Saphnelo获得欧盟批准用于系统性红斑狼疮, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=62eb29900255)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1436326, encodeId=6f3514363262d, content=<a href='/topic/show?id=22f8e71238d' target=_blank style='color:#2F92EE;'>#红斑#</a>, objectTitle=血清淀粉样蛋白 A 与白蛋白比值作为预测系统性红斑狼疮活动性、严重程度和预后不良的潜在生物标志物, objectType=article, longId=295716, objectId=f28a295e160c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f28a295e160c, replyNumber=0, likeNumber=69, createdTime=2022-02-17, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f28a295e160c, moduleTitle=血清淀粉样蛋白 A 与白蛋白比值作为预测系统性红斑狼疮活动性、严重程度和预后不良的潜在生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f28a295e160c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1436325, encodeId=2ea5143632569, content=<a href='/topic/show?id=22f8e71238d' target=_blank style='color:#2F92EE;'>#红斑#</a>, objectTitle=欧洲药理学杂志：组织蛋白酶 S 抑制剂 ASP1617 作为系统性红斑狼疮治疗的潜在益处, objectType=article, longId=295713, objectId=39ac295e1352, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=39ac295e1352, replyNumber=0, likeNumber=78, createdTime=2022-02-17, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=39ac295e1352, moduleTitle=欧洲药理学杂志：组织蛋白酶 S 抑制剂 ASP1617 作为系统性红斑狼疮治疗的潜在益处, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=39ac295e1352)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1436324, encodeId=768d1436324fb, content=<a href='/topic/show?id=22f8e71238d' target=_blank style='color:#2F92EE;'>#红斑#</a>, objectTitle=JAAD：银屑病停用全身性类固醇后的红斑和反弹现象研究, objectType=article, longId=295023, objectId=722329502396, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=722329502396, replyNumber=0, likeNumber=72, createdTime=2022-02-03, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=722329502396, moduleTitle=JAAD：银屑病停用全身性类固醇后的红斑和反弹现象研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=722329502396)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1436323, encodeId=c2e1143632335, content=<a href='/topic/show?id=22f8e71238d' target=_blank style='color:#2F92EE;'>#红斑#</a>, objectTitle=TAMD：系统性红斑狼疮侵袭性真菌感染的流行病学和风险, objectType=article, longId=294847, objectId=9e8229484e9b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9e8229484e9b, replyNumber=0, likeNumber=93, createdTime=2022-01-30, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9e8229484e9b, moduleTitle=TAMD：系统性红斑狼疮侵袭性真菌感染的流行病学和风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9e8229484e9b)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

红斑

2020-05-29

zhouqu_8 (审核中...)

前往app查看评论内容

#红斑#

Ann Hematol：免疫性血小板减少症发展为系统性红斑狼疮的潜在危险因素：中国儿童病例对照研究

2022-05-20

zhouqu_8 (审核中...)

前往app查看评论内容

#红斑#

A&R：系统性红斑狼疮的共享和亚洲特异性基因座的鉴定以及III型干扰素信号传导和溶酶体功能在该疾病中作用的证据：一项多祖先全基因组关联研究

2022-05-19

zhouqu_8 (审核中...)

前往app查看评论内容

#红斑#

病程越长越容易复发？牢记4点，让红斑狼疮不敢复发！

2022-05-17

zhouqu_8 (审核中...)

前往app查看评论内容

#红斑#

Arch Dermatol Res：非手术短波射频治疗轻至中度红斑型酒糟鼻

2022-05-12

zhouqu_8 (审核中...)

前往app查看评论内容

#红斑#

C3、C4补体在系统性红斑狼疮的诊疗中为何如此重要？

2022-04-26

zhouqu_8 (审核中...)

前往app查看评论内容

#红斑#

Rheumatology：暴露-反应分析在系统性红斑狼疮患者阿尼福卢单抗更佳剂量方案选择中的应用

2022-03-23

zhouqu_8 (审核中...)

前往app查看评论内容

#红斑#

Arthritis Rheumatol：Bruton‘s酪氨酸激酶抑制剂Fenebrutinib治疗系统性红斑狼疮的疗效、安全性和药效学效应研究

2022-03-21

zhouqu_8 (审核中...)

前往app查看评论内容

#红斑#

J Autoimmun：皮肤CD4+Trm细胞区分急性皮肤红斑狼疮和局限性盘状红斑狼疮/亚急性皮肤红斑狼疮及其他皮肤病

2022-03-21

zhouqu_8 (审核中...)

前往app查看评论内容

#红斑#

JEADV:1例斑块型银屑病患者在接种新冠疫苗后出现泛发性脓疱性银屑病红斑，并用risankizumab成功治疗

2022-03-20

zhouqu_8 (审核中...)

前往app查看评论内容

#红斑#

Front Immunol：单细胞分辨下系统性红斑狼疮患者外周血单核细胞染色质可及性的研究

2022-03-19

zhouqu_8 (审核中...)

前往app查看评论内容

#红斑#

NEJM：iberdomide治疗系统性红斑狼疮II期结果喜人

2022-03-19

zhouqu_8 (审核中...)

前往app查看评论内容

#红斑#

Mayo Clin Proc：系统性红斑狼疮和抗磷脂抗体综合征患者发生生物瓣膜血栓的极端病例

2022-03-11

zhouqu_8 (审核中...)

前往app查看评论内容

#红斑#

ARD：EULAR对风湿性和肌肉骨骼疾病（包括系统性红斑狼疮和抗磷脂综合征）心血管风险管理的建议

2022-02-25

zhouqu_8 (审核中...)

前往app查看评论内容

#红斑#

ARD：系统性红斑狼疮的抗RNP抗体与干扰素基因特征相关，与降低的补体水平无关

2022-02-25

zhouqu_8 (审核中...)

前往app查看评论内容

#红斑#

TAMD：FRAX工具评估系统性红斑狼疮患者骨折风险

2022-02-21

zhouqu_8 (审核中...)

前往app查看评论内容

#红斑#

阿斯利康旗下的Saphnelo获得欧盟批准用于系统性红斑狼疮

2022-02-19

zhouqu_8 (审核中...)

前往app查看评论内容

#红斑#

血清淀粉样蛋白 A 与白蛋白比值作为预测系统性红斑狼疮活动性、严重程度和预后不良的潜在生物标志物

2022-02-17

zhouqu_8 (审核中...)

前往app查看评论内容

#红斑#

欧洲药理学杂志：组织蛋白酶 S 抑制剂 ASP1617 作为系统性红斑狼疮治疗的潜在益处

2022-02-17

zhouqu_8 (审核中...)

前往app查看评论内容

#红斑#

JAAD：银屑病停用全身性类固醇后的红斑和反弹现象研究

2022-02-03

zhouqu_8 (审核中...)

前往app查看评论内容

#红斑#

TAMD：系统性红斑狼疮侵袭性真菌感染的流行病学和风险

2022-01-30

科室
- - 订阅+
  - 更多科室
工具
服务